+499.5%
MRNA vs ONON
-37.3%
+536.8%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | ONON | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -1.3% | -0.9% | -2.0% |
| 7D | +5.5% | -3.0% | +8.5% | +6.0% |
| 30D | +158.7% | -26.7% | +185.4% | +169.9% |
| 3M | +182.1% | -25.3% | +207.4% | +193.6% |
| 6M | +151.8% | -35.3% | +187.1% | +166.4% |
| YTD | +393.6% | -39.8% | +433.3% | +422.8% |
| 1Y | +499.5% | -39.2% | +538.7% | +563.6% |
| All | +499.5% | -37.3% | +536.8% | +563.6% |
Cumulative growth
Daily Returns
Daily percentage return beside ONON.
Daily Out/Under-Performance
Portfolio return minus ONON return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ONON return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded ONON wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling